story of the week
Vinorelbine With Pertuzumab and Trastuzumab as First Line in HER2+ Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Breast Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and Efficacy of Vinorelbine in Combination With Pertuzumab and Trastuzumab for First-Line Treatment of Patients With HER2-Positive Locally Advanced or Metastatic Breast Cancer: VELVET Cohort 1 Final Results
Breast Cancer Res 2016 Dec 13;[EPub Ahead of Print], EA Perez, JM López-Vega, T Petit, C Zamagni, V Easton, J Kamber, E Restuccia, M AnderssonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.